Humana (HUM): Today's Featured Health Care Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Humana ( HUM) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.4%. By the end of trading, Humana rose 78 cents (1.1%) to $75.33 on light volume. Throughout the day, 1.4 million shares of Humana exchanged hands as compared to its average daily volume of 2.2 million shares. The stock ranged in a price between $74.79-$75.63 after having opened the day at $74.79 as compared to the previous trading day's close of $74.55. Other companies within the Health Care sector that increased today were: Cormedix ( CRMD), up 33.3%, Amicus Therapeutics ( FOLD), up 14.8%, CAS Medical Systems ( CASM), up 12.5%, and Sucampo Pharmaceuticals Inc. A ( SCMP), up 11.5%.
  • ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.

Humana Inc. operates as a health care company that offers a range of insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. Humana has a market cap of $12.09 billion and is part of the health services industry. The company has a P/E ratio of 9.9, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are down 14.9% year to date as of the close of trading on Wednesday. Currently there are 15 analysts that rate Humana a buy, no analysts rate it a sell, and eight rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.
null

If you liked this article you might like

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

Boeing, Pure Storage, Activision Blizzard: 'Mad Money' Lightning Round

The Makings of Another Huge Rebound?

Healthcare Management Stocks Look Too Pricey for Activists

Tenet Dives After Worse Than Expected Quarter Leads to Lower 2017 Outlook